tbuckley/cabot-search huggingface dataset:
Coffee Consumption and Type 2 Diabetes Mellitus
Authors: Donald A. Gerber
Journal: Annals of Internal Medicine (2004)

Letters17 August 2004Coffee Consumption and Type 2 Diabetes MellitusDonald A. Gerber, MDDonald A. Gerber, MDFrom State University of New York Downstate Medical Center, Brooklyn, NY 11203.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-141-4-200408170-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Salazar-Martinez and colleagues (1) reported that coffee protects against type 2 diabetes mellitus, but their data can also be interpreted to suggest quite the opposite, namely that coffee statistically significantly accelerates the development of diabetes. To illustrate, let us assume that coffee accelerates the development of diabetes in a subgroup of patients but that these patients would probably develop diabetes later in life if they consumed less or no coffee. If this is true, Salazar-Martinez and colleagues, whose study protocol called for excluding persons with known diabetes, would have selectively excluded some participants with coffee-induced early diabetes. ...References1. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al . Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140:1-8. [PMID: 14706966] LinkGoogle Scholar2. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477-8. [PMID: 12433517] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From State University of New York Downstate Medical Center, Brooklyn, NY 11203. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCoffee Consumption and Risk for Type 2 Diabetes Mellitus Eduardo Salazar-Martinez , Walter C. Willett , Alberto Ascherio , JoAnn E. Manson , Michael F. Leitzmann , Meir J. Stampfer , and Frank B. Hu Coffee Consumption and Type 2 Diabetes Mellitus Frank B. Hu , Walter C. Willett , and JoAnn E. Manson Coffee Consumption and Type 2 Diabetes Mellitus Donald B. Louria Coffee Consumption and Type 2 Diabetes Mellitus Benjamin Schaefer Coffee Consumption and Type 2 Diabetes Mellitus Federico Soriguer , Gemma Rojo-Martínez , and Isabel Esteva de Antonio Coffee Consumption and Type 2 Diabetes Mellitus John H. Glaser and Sheila K. Glaser Metrics Cited ByEffect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetesCoffee as a Functional Beverage 17 August 2004Volume 141, Issue 4Page: 323KeywordsCaffeineCoffeeStatistical dataType 2 diabetes ePublished: 17 August 2004 Issue Published: 17 August 2004 CopyrightCopyright © 2004 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
EFFICACY OF INTRAGASTRIC BALLOONS FOR WEIGHT LOSS IN OVERWEIGHT AND OBESE ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors: APST Kotinda, DTH de Moura, IB Ribeiro, S Singh, M Coronel, WM Bernardo, C C Thompson, EGH de Moura
Journal: Endoscopy (2020)

Aims More than 1.9 billion adults are overweight, and 650 million are obese globally, and yet these overwhelming statistics continue to rise. Endoscopic bariatric and metabolic therapies (EBMTs) are minimally invasive procedures developed to complement the obesity treatment. Intragastric balloons (IGB) are the most widely used EBMT, but studies have shown variable weight loss outcomes. We aimed to evaluate the efficacy of IGBs in comparison to lifestyle Interventions alone for weight loss in overweight and obese patients.
IMPACT OF SECOND GENERATION ENDOCUFF-ASSISTED COLONOSCOPY VS. STANDARD COLONOSCOPY ON ADENOMA DETECTION RATE IN ROUTINE PRACTICE: A CLUSTER-RANDOMIZED CROSSOVER TRIAL
Authors: D Karsenti, G Tharsis, B Perrot, P Cattan, G Tordjman, F Venezia, E Zrihen, D Gillot, A Gillet, C Hagege, J Samama, I Etienney, JP Lab, B Guigui, J Zago, B Benkhessou, P Burtin, M Cavicchi, PD Paris-Bercy
Journal: Endoscopy (2020)

Aims Endocuff vision (ECV) is the second generation of a recent device designed to improve polyp detection. The aim of this study was to evaluate the impact of ECV on adenoma detection rate (ADR) in routine colonoscopy.
FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms
Authors: Hubert H. Chuang, Dustin J. Emery, Richelle Millican Campbell, Yang Lu
Journal: Clinical Nuclear Medicine (2020)

A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.
FDG PET/CT Findings in an Asymptomatic Case of Confirmed COVID-19
Authors: Patrick Martineau, Biniam Kidane
Journal: Clinical Nuclear Medicine (2020)

In the current and rapidly worsening pandemic, patients with COVID-19 may undergo imaging with FDG PET/CT. Because a significant proportion of infected patients may be asymptomatic, incidental discovery on a PET/CT scan performed for unrelated reasons can occur. Because of the highly infectious nature of this agent, it is important that interpreting physicians be aware of the typical imaging findings to identify potentially affected patients. We present the case of an asymptomatic patient referred for FDG PET/CT imaging of a lung nodule who demonstrated the typical CT findings of COVID-19 infection and was subsequently found to be positive on testing.
Covid-19: planning a future that focuses on sustainability, health, and social value
Authors: Ali Mehdi
Journal: BMJ (2020)

The need for international solidarity, as discussed by Kickbusch and colleagues, has never been greater.1 Political, economic, social, technological, legal, and environmental factors are key determinants of society, of which healthcare is an integral part. The effects of covid-19 on these factors have been elaborated widely in different ways. Mankind faces many challenges in recovering from the existential threat these pose.

Political gain, financial return, and material acquisition are key barriers …
ACUTE COLONIC OBSTRUCTION IN PATIENTS TREATED WITH PALLIATIVE INTENTION. FACTORS RELATED TO MORTALITY
Authors: I Couto-Worner, A Guerrero-Montañés, M López-Álvarez, L Yáñez-González-Dopeso, MT Seoane-Pillado, PA Alonso-Aguirre
Journal: Endoscopy (2020)

Aims To evaluate factors involved in mortality in patients who presented an acute colonic obstruction treated without curative intention. Our objective was to determine the influence of endoscopic stent.
UNSEDATED ULTRATHIN ENDOSCOPY FOR VARICEAL SURVEILLANCE IN THE OUTPATIENT SETTING – EVIDENCE INTO PRACTICE
Authors: A Eqbal, T Wickremeratne, S Turner, S Higgins, A Sloss, J Mitchell, J O’Beirne
Journal: Endoscopy (2020)

Aims Risk of bleeding from oesophageal varices and the need for prophylaxis is determined by the endoscopic appearance of varices and therefore upper gastrointestinal (UGI) endoscopy is recommended by guidelines at diagnosis of cirrhosis and regular intervals thereafter. However, the point prevalence of varices is low (25%) meaning that the majority of these endoscopies are unnecessary. Recent advances in endoscope technology have resulted in the development of narrow diameter or ultrathin (< 6 mm) endoscopes which have the advantage of being more tolerable than conventional UGI endoscopes. We hypothesised that unsedated ultrathin endoscopy for diagnosis of varices could be implemented in the outpatient setting and would be acceptable to patients.
THE YIELD OF FOCUSSED ENDOSCOPIC ULTRASOUND IN PATIENTS WITH UNEXPLAINED DILATATION OF COMMON BILE DUCT AND OR PANCREATIC DUCT AND CORRELATION WITH LIVER FUNCTION TESTS
Authors: V Parihar, G Offiah, Y Bashir, R Ballester-Clau, K Hazel, G Mellotte, NP Breslin, BM Ryan
Journal: Endoscopy (2020)

Aims To investigate factors that are associated with positive findings at EUS in patients with dilated ducts and correlation with LFTs.
ENDOSCOPIC ULTRASOUND DIAGNOSIS OF A MAIN DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM IN A TYPE 1 PANCREAS DIVISUM
Authors: M Moris, ÁT Lantarón, C Del Pozo Calzada, M Pascual Mato, FJJ Pérez
Journal: Endoscopy (2020)

A dilated main pancreatic duct (MPD) was described in a CT. A linear endoscopic ultrasound (EUS) was performed.
INITIAL EXPERIENCE WITH SAME SESSION ENDOSCOPIC FUNDOPLICATION AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM+F) - SHORT TERM CLINICAL OUTCOMES FROM A SINGLE CENTER
Authors: P Dashatwar, A Bapaye, S Dharamsi, R Pujari, H Gadhikar
Journal: Endoscopy (2020)

Aims Post-POEM gastroesophageal reflux (GER) is reported in up to 50% patients. POEM with endoscopic fundoplication (POEM+F) is a novel NOTES procedure combining endoscopic fundoplication with POEM. This study reports feasibility, safety and short-term outcomes after POEM+F especially with reference to prevention of post POEM GER.
SYMPTOMS PREDICTIVE OF ACUTE MYOCARDIAL INFARCTION IN THE TROPONIN ERA: ANALYSIS FROM THE TRAPID-AMI STUDY
Authors: Carlos Calle Muller, James McCord, Alexander Michaels, Richard Nowak, Evangelos Giannitsis, Richard Body, Michael Christ, Bertil Lindahl, Christopher DeFilippi, Robert Christenson, Garnet Bendig, Gordon Jacobsen, Christian Mueller
Journal: Journal of the American College of Cardiology (2016)
Uncertainty and COVID-19: how are we to respond?
Authors: Jonathan Koffman, Jamie Gross, Simon Noah Etkind, Lucy Selman
Journal: Journal of the Royal Society of Medicine (2020)

As if writing prophetically about the global COVID-19 pandemic, in 1984 Eddy suggested, ‘Uncertainty creeps into medical practice through every pore. Whether a physician is defining a disease, making a diagnosis, selecting a procedure, observing outcomes, assessing probabilities, assigning preferences, or putting it all together, he (or she) is walking on very slippery terrain’.1 COVID-19 has rapidly become a disease associated with unbridled uncertainty with its aetiology and management, for the healthcare systems and health professionals who provide care, and among its ultimate victims, patients and their families.

Frustratingly, uncertainty is not a simple or easily defined concept and situations of uncertainty often result from several inter-related factors. It has been characterised as an inadequate understanding, a sense of incomplete, ambiguous or unreliable information, and conflicting alternatives.2 In the current COVID-19 pandemic, any given situation of uncertainty may be made up of several of these factors, but equally, there are many forms of uncertainty.3 Irrespective of its origin, we know uncertainty matters because when suppressed and ignored, consciously and subconsciously, it has potential to negatively impact on patients, their family, at a profoundly emotional level.4 It also affects health professionals and it has been argued their tolerance of uncertainty can affect levels of investigation, patient safety, as well as healthcare resource use.5 The authors of this commentary -- an ITU physician, a palliative care physician and two social scientists -- critically synthesise evidence from this grey area of uncertainty associated with COVID-19 and argue it is inescapable. In the face of the global proliferation of this disease and sense of urgency, they unite to consider how, in an area that is neither black nor white, practical solutions that can be harnessed now, not to ‘outsmart’ uncertainty, but to acknowledge its presence and, where possible, to work more effectively and efficiently alongside it to improve patient and family care at a critical moment in their lives (Tables 1 and ​and22). 

Table 1.

Recommendations to address disease and health system uncertainties.
COMPARISON OF LONG-TERM OUTCOMES BETWEEN STRETTA AND ANTI-REFLUX ENDOSCOPIC SURGERY (ARES) IN REFRACTORY GERD PATIENTS
Authors: DS Noh, JY Cho
Journal: Endoscopy (2020)

Aims Traditionally, the use of proton pump inhibitors (PPI) in gastroesophageal reflux disease (GERD) is well-known as a primary treatment. However, approximately 10 percent of patients failed to respond to PPI treatment. Recently, noble endoscopic techniques, such as anti-reflux endoscopic surgery (ARES) and Stretta, have been developed. The aim of this study is to compare the long term outcomes and efficacy between anti-reflux endoscopic surgery (ARES) and Stretta procedure.
COVID-19 and the Need for a National Health Information Technology Infrastructure
Authors: Dean F. Sittig, Hardeep Singh
Journal: JAMA (2020)

The need for timely, accurate, and reliable data about the health of the US population has never been greater.Critical questions include the following: (1) how many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and how many are affected by the disease it causes-novel coronavirus disease 2019 (COVID-19) in a given geographic area;(2) what are the age and race of these individuals; (3) how many people sought care at a health care facility; (4) how many were hospitalized; (5) within individual hospitals, how many patients required intensive care, received ventilator support, or died; and ( 6) what was the length of stay in the hospital and in the intensive care unit for patients who survived and for those who died.In an attempt to answer some of these questions, on March 29, 2020, Vice President Mike Pence requested all hospitals to email key COVID-19 testing data to the US Department of Health and Human Services (HHS). 1 The National Healthcare Safety Network, an infection-tracking system of the CDC, was tasked with coordinating additional data collection through a new web-based COVID-19 module.Because reporting is optional and partial reporting is allowed, it is unclear how many elements of the requested information are actually being collected and how they will be used.Although the US is one of the most technologically advanced societies in the world and one that spends the most money on health care, this approach illustrates the need for more effective solutions for gathering COVID-19 data at a national level.
REAL-TIME COMPUTER AIDED DETECTION OF COLORECTAL NEOPLASIA AT COLONOSCOPY ACCORDING TO THE INDICATION: A RANDOMIZED CLINICAL TRIAL
Authors: A Repici, M Badalamenti, R Maselli, F Radaelli, E Randonotti, G Pellegatta, E C Ferrara, P A Galtieri, A Anderloni, S Carrara, V Craviotto, M Spadaccini, L Lamonaca, A Capogreco, A Alkandari, A Andrealli, T Rösch, M Wallace, P Sharma, C Hassan
Journal: Endoscopy (2020)

Aims One fourth of colorectal neoplasia is missed at colonoscopy, representing the main cause of interval Colorectal-Cancer(CRC). Deep-learning (DL) systems allow Computer-Aided Polyp-Detection (CADe) with high-accuracy in retrospective studies. We performed a multicenter Randomized clinical trial (RCT) of 700 patients who underwent colonoscopy for: gastrointestinal-symptoms (23%), fecal immunochemical test (29.6%), primary screening (22%),postpolypectomy-surveillance (23.4). Aim was to assess safety and efficacy of CADe system in improving lesion-detection.
IMPACT OF QUALITY CLEANSING IN A COLORRECTAL CANCER SCREENING PROGRAM
Authors: NF Fernández, AR D´Jesús, LC Gómez, AM Turnes, L De Castro Parga, AG Martínez, BR Mosquera, VH Ramírez, AS Barreira, IR Prada
Journal: Endoscopy (2020)

Aims Our aims was to assess if lower levels of cleansing score than the optimal one (BBPS < 9, with score per segment ≥2) have a negative impact in ADR in medium risk patients.A quality colonoscopy that guarantees detection and resection of neoplasia is mandatory in colorectal cancer screening (CRC). There is controversy whether adequate cleansing (BBPS ≥ 6) can be considered sufficient in CCR screening colonoscopy (CCCCR). The adenoma detection rate (ADR) is the main quality parameter.
Abstract 12187: Association of Primary Care Providers’ Views of Statins for Primary Prevention and Statin Prescription
Authors: Jeffrey D Clough, Seth S Martin, Ann M Navar, Li Lin, Natalie C Hardy, Dwight Scott, Ursula Rogers, Lesley H Curtis
Journal: Circulation (2018)

Introduction: The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet...
The Physiologic Basis for Therapy of Classic Hemophilia (Factor VIII Deficiency) and Related Disorders
Authors: N. Raphael Shulman, Dale H. Cowan, Eugene P. Libre, Stanley P. Watkins, Victor J. Marder
Journal: Annals of Internal Medicine (2020)

Excerpt Dr. N. Raphael Shulman: In the past few years much new information has been acquired concerning the pathophysiology and therapy of classic hemophilia and other diseases involving factor VII...
A serological assay to detect SARS-CoV-2 seroconversion in humans
Authors: Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, Thi H. O. Nguyen, Veronika Chromikova, Meagan McMahon, Kaijun Jiang, Guha Asthagiri Arunkumar, Denise Jurczyszak, Jose Polanco, Maria Bermudez-Gonzalez, Giulio Kleiner, Teresa Aydillo, Lisa Miorin, Daniel S. Fierer, Luz Amarilis Lugo, Erna Milunka Kojic, Jonathan Stoever, Sean T. H. Liu, Charlotte Cunningham-Rundles, Philip L. Felgner, Thomas Moran, Adolfo García-Sastre, Daniel Caplivski, Allen C. Cheng, Katherine Kedzierska, Olli Vapalahti, Jussi M. Hepojoki, Viviana Simon, Florian Krammer
Journal: Nature Medicine (2020)
NON-INVASIVE COLORECTAL NEOPLASMS REFERRED TO SURGERY: A PERFORMANCE KEY MEASURE FOR SCREENING PROGRAMS
Authors: F Iacopini, C Hassan, S Frontespezi, E Mattei, V Ceci, S Brighi, P Fedeli, S Angeletti, G Fanello, V D’Ovidio, MG De Palo, A Cocco, A Forte, G Forti, C Grossi, N Altavilla, G Dimito, G Occhigrossi, E Di Giulio, M Bazuro, R Ballanti, R Faggiani, A Scozzarro, E Capezzuto, F Baldi, D Baiocchi, A Barca, G Costamagna
Journal: Endoscopy (2020)

Aims A large proportion of neoplasms undergo curative endoscopic resection if second-look is performed before surgery. Operator competency and limited access to advanced resection techniques may have an unfavorable impact on colorectal cancer screening.
THREE’S A CROWD? A SINGLE CENTRE RETROSPECTIVE REVIEW OF ENDOSCOPIC INTERVENTION FOR UPPER GASTROINTESTINAL PEPTIC ULCER DISEASE
Authors: M McKenna-Barry, D Cheriyan, G Harewood, J Ryan, A O’Toole, S Patchett, K Boland
Journal: Endoscopy (2020)

Aims Bleeding upper GI ulcers is a common indication for endoscopy. Its management is focused on resuscitation, pharmacological therapy and endoscopic management. ESGE does not recommend the use of adrenaline injection as monotherapy for bleeding ulcers due to the risk of rebleeding. We aimed to review departmental experience of stable non-variceal upper GI, assessing the indication and number of endoscopic interventions for bleeding upper GI ulcers.
THE EFFICACY AND SAFETY OF ENDOSCOPIC TRANS-PAPILLARY GALLBLADDER STENTING TO REPLACE PERCUTANEOUS CHOLECYSTOSTOMY IN POOR SURGICAL CANDIDATES
Authors: HK Chon, TH Kim
Journal: Endoscopy (2020)

Aims Endoscopic trans-papillary gallbladder stenting (ETGBS) is a useful alternative to percutaneous cholecystostomy (PC) in patients with acute cholecystitis when cholecystectomy must be delayed or cannot be performed. However, there are few data on the efficacy and safety of ETGBS replacement of PC in patients unfit for cholecystectomy.
LEARNING CURVE FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL TUMORS IN A WESTERN CENTER - A SINGLE-OPERATOR LEARNING CURVE ANALYSIS
Authors: C Félix, P Barreiro, R Mendo, I Carina, JA Rodrigues, C Chagas
Journal: Endoscopy (2020)

Aims Colorectal endoscopic submucosal dissection (ESD) is widely implemented in many Asian countries as standard treatment of early colorectal neoplasms. However, ESD experience is still limited to a handful of centers outside Asia, leading to few reports describing the learning curve in this setting. We aimed to evaluate the learning curve of rectal ESD in a western center.
Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's Disease
Authors: J A Obeso, C W Olanow, M C Rodriguez-Oroz, P Krack, R Kumar, A E Lang
Journal: New England Journal of Medicine (2001)

Increased neuronal activity in the subthalamic nucleus and the pars interna of the globus pallidus is thought to account for motor dysfunction in patients with Parkinson's disease. Although creating lesions in these structures improves motor function in monkeys with induced parkinsonism and patients with Parkinson's disease, such lesions are associated with neurologic deficits, particularly when they are created bilaterally. Deep-brain stimulation simulates the effects of a lesion without destroying brain tissue.We performed a prospective, double-blind, crossover study in patients with advanced Parkinson's disease, in whom electrodes were implanted in the subthalamic nucleus or pars interna of the globus pallidus and who then underwent bilateral high-frequency deep-brain stimulation. We compared scores on the motor portion of the Unified Parkinson's Disease Rating Scale when the stimulation was randomly assigned to be turned on or off. We performed unblinded evaluations of motor function preoperatively and one, three, and six months postoperatively.Electrodes were implanted bilaterally in 96 patients in the subthalamic-nucleus group and 38 patients in the globus-pallidus group. Three months after the procedures were performed, double-blind, crossover evaluations demonstrated that stimulation of the subthalamic nucleus was associated with a median improvement in the motor score (as compared with no stimulation) of 49 percent, and stimulation of the pars interna of the globus pallidus with a median improvement of 37 percent (P<0.001 for both comparisons). Between the preoperative and six-month visits, the percentage of time during the day that patients had good mobility without involuntary movements increased from 27 percent to 74 percent (P<0.001) with subthalamic stimulation and from 28 percent to 64 percent (P<0.001) with pallidal stimulation. Adverse events included intracranial hemorrhage in seven patients and infection necessitating removal of the leads in two.Bilateral stimulation of the subthalamic nucleus or pars interna of the globus pallidus is associated with significant improvement in motor function in patients with Parkinson's disease whose condition cannot be further improved with medical therapy.
LONG-TERM OUTCOMES AFTER ENDOSCOPIC REMOVAL OF MALIGNANT COLORECTAL POLYPS – RESULTS FROM A RETROSPECTIVE COHORT STUDY
Authors: A Fábián, R Bor, B Vasas, T Tóth, K Szántó, A Bálint, K Farkas, Á Milassin, D Pigniczki, M Rutka, T Molnár, Z Szepes
Journal: Endoscopy (2020)

Aims To investigate long-term outcomes after endoscopic removal of malignant colorectal polyps (invasion confined to the submucosa).
THE LAMS-IN-LAMS RESCUE TECHNIQUE TO RESOLVE AN EXTREME BURIED STENT
Authors: M Izquierdo, F Bas-Cutrina, JB Gornals
Journal: Endoscopy (2020)

Four weeks after a complete resolution of a pancreatic collection, the proximal end of the LAMS (10x10-mm, HXS) was totally covered by gastric mucosa, and the buried stent was located 1-cm far from the gastric wall by fluoroscopy/EUS image. Rescue strategy: (I) ostomy repermeabilization by EUS-guided intervention (19-G needle, 6-Fr cystotome and 8-mm balloon); (II) placement of second coaxial LAMS (15x10-mm, HXS) plus a pigtail; (III) Four-weeks after, migration of the second LAMS and persistence of the pigtail maintaining the ostomy permeable. Ostomy tract dilation allowing a first endoscopic identification of the buried LAMS, and a successful extraction.